Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Sabrient QES Index Series
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
»
Feed aggregator
»
Sources
https://seekingalpha.com
URL:
https://seekingalpha.com
Updated:
29 min ago
Options for a U.S. exit from the Iran conflict ‘not very good’ – former U.S. ambassador
Wed, 04/01/2026 - 12:21
Mario and Luigi are back: Nintendo eyes another billion-dollar blockbuster
Wed, 04/01/2026 - 12:17
Churchill Downs scores legal victory in Kentucky federal court
Wed, 04/01/2026 - 12:16
Argan's Earnings Report Wasn't Luck, It Was A Sign
Wed, 04/01/2026 - 12:16
ORIC Pharmaceuticals: Updates Did Not Bode Well For This Valuation
Wed, 04/01/2026 - 12:14
IDRV: Taking This Self-Driving And EV ETF For A Spin
Wed, 04/01/2026 - 12:12
Q1 2026: Eerily Similar To Last Year
Wed, 04/01/2026 - 12:09
Beyond Meat: Sales Struggles Continue
Wed, 04/01/2026 - 12:08
Cheap drone ‘Lucas’ is said to signal shift in U.S. war strategy
Wed, 04/01/2026 - 12:08
Micron: The Selloff Didn't Break The Setup
Wed, 04/01/2026 - 12:07
Slackbot event showcases 'significant' productivity boost, 'structural' advantage: BTIG
Wed, 04/01/2026 - 12:05
A Different Supply-Side Shock
Wed, 04/01/2026 - 12:05
Go Get Your Own Oil: The False Promise Of Peace
Wed, 04/01/2026 - 12:04
Abbott: A Brighter Investment Case Heading Into Q1 Earnings (Rating Upgrade)
Wed, 04/01/2026 - 12:04
Bouncing Into April?
Wed, 04/01/2026 - 12:00
Dave & Buster's Entertainment: Why I'm Waiting And Downgrading My Price Target
Wed, 04/01/2026 - 11:57
Micron: Great Businesses Can Be Bad Trades (Rating Downgrade)
Wed, 04/01/2026 - 11:50
Lumentum: The AI Optics Catalyst Is Just Getting Started
Wed, 04/01/2026 - 11:47
Unity Bancorp Stands Out From The Small-Cap Crowd
Wed, 04/01/2026 - 11:46
A Turning Point For Crispr Therapeutics As Commercial Growth Accelerates
Wed, 04/01/2026 - 11:43
Pages
« first
‹ previous
…
1812
1813
1814
1815
1816
1817
1818
1819
1820
…
next ›
last »